Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.
This study is a preliminary single-group pre-post design aimed at developing and evaluating the feasibility of an ACT-based nursing intervention for distress management in patients with ovarian cancer. A total of 25 ovarian cancer patients who consent to participate will be enrolled in the study. Paticipants will receive a one-time ACT-based nursing intervention lasting approximately 60 minutes.
The researcher will coordinate schedules with participants to deliver the ACT-based nursing intervention using Zoom, a video conferencing platform which minimizes time and location constraints. Before the intervention, the research will ensure that the participants' video conferencing is working properly to minimize potential difficulties during the session.
Following the single-session intervention, the researcher will send a daily Google Form link to participants for seven consecutive days. Participants will be encouraged to access the link and complete self-monitoring surveys to reinforce the key components addressed in the program.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A | Experimental | Experimental group with application of ACT-based nursing intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ACT-based nursing intervention | Other | ACT-based nursing intervention is a 1:1 single online session with a nurse, which takes about 60 minutes followed by a daily self-monitoring survey for one week, which encourages patients to practice ACT. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline psychological distress on the last day of self-monitoring (Day 8) | Psychological distress measured by Distress Thermometer. | Psychological distress will be assessed at baseline and on the last day of self-monitoring (Day 8). |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline depression | depression measured by the Hospital Anxiety and Depression Scale (HADS). | within 3 weeks after the last day of self-monitoring (window: 7 days) |
| Change from anxiety |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jiyeon Lee, RN, NP, Ph.D | Contact | 82-2-2228-3255 | jiyeonest@yuhs.ac |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anxiety by the Hospital Anxiety and Depression Scale (HADS).
| within 3 weeks after the last day of self-monitoring (window: 7 days) |
| Change from fear of cancer recurrence | Fear of cancer recurrence measured by the Fear of Cancer Recurrence Index (FCRI). | within 3 weeks after the last day of self-monitoring (window: 7 days) |
| Change from psychological flexibility | Psychological flexibility measured by the Acceptance and Action Questionnaire-II (AAQ-II). | within 3 weeks after the last day of self-monitoring (window: 7 days) |
| Change from quality of life | Quality of life measured by the ECORTC QLQ C-30. | within 3 weeks after the last day of self-monitoring (window: 7 days) |
| Change from symptoms | Symptoms measured by the EORTC QLQ-OV28. | within 3 weeks after the last day of self-monitoring (window: 7 days) |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |